On March 4, the Grimaud family group declared to the AMF that it had fallen below the threshold of 15% of Valneva's voting rights, to hold 9.22% of the vaccine company's capital and 14.92% of its voting rights.

This threshold was crossed following the sale of shares on the market. Groupe Grimaud la Corbière crossed the same threshold individually downwards, to hold 8.73% of the capital and 14.11% of the voting rights.

Copyright (c) 2024 CercleFinance.com. All rights reserved.